Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

Comment by Qh1234on Dec 08, 2015 1:06pm
106 Views
Post# 24365563

RE:RE:RE:CIBC

RE:RE:RE:CIBC
Thanks Iscfa. I noticed that Scotia bank use a very similar multiplier of 9.15. It reasons that "the group of larger global specialty pharma trades at an average of 12.2x. We believe the ~40% discount to the group is too large; a 25% discount would be more appropriate for a company like Merus, in our view." Qh1234
<< Previous
Bullboard Posts
Next >>